Table 2.
Baseline parameters of included patients.
| n (total) | 64 | ||
|---|---|---|---|
| Female gender | 40 (63%) | ||
| Objective xerophthalmia, n (%) | 55 (86%) | ||
| Objective xerostomia, n (%) | 30 (47%) | ||
| Anti‐SSA(Ro) antibodies positive, n (%) | 28 (44%) | ||
| Anti‐SSB(La) antibodies positive, n (%) | 6 (9%) | ||
| Minor salivary gland biopsy positive, n (%) | 48 (75%) | ||
| Diagnostic score, mean | 4.9 |
| All | Female | Male | |
|---|---|---|---|
| Age [in years] at time of testing, median (range) | 59 (32–84) | 54 (33–84) | 70 (50–83) |
| Years of education, median (range) | 13 (8–18) | 13 (8–18) | 12 (8–17) |